dehydroepiandrosterone sulfate has been researched along with Adenocarcinoma, Basal Cell in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (21.43) | 18.7374 |
| 1990's | 7 (50.00) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Gislefoss, RE; Lagergren, J; Langseth, H; Mattsson, F; Ness-Jensen, E; Rabbani, S; Xie, SH | 1 |
| Balk, S; Brown, M; Figg, WD; Freedman, M; Kantoff, PW; Lee, GS; Mostaghel, E; Nakabayashi, M; Oh, WK; Pomerantz, M; Regan, M; Ross, R; Sharifi, N; Sun, T; Taplin, ME; Werner, L; Xie, W; Yang, M | 1 |
| Beranek, PA; Bonney, RC; James, VH; Jones, DL; Reed, MJ; Scanlon, MJ | 1 |
| Bennett, P; Blaakaer, J; Bock, J; Høgdall, CK; Hørding, U; Micic, S; Toftager-Larsen, K | 1 |
| Bennett, P; Blaakaer, J; Bock, J; Daugaard, S; Høgdall, CK; Hørding, U; Toftager-Larsen, K | 1 |
| Boros, LG; Brandes, JL; Ellison, EC; Fisher, WE; Johnson, JA; Melvin, WS; Muscarella, P; Schirmer, WJ | 1 |
| Chrisp, C; Miller, RA | 1 |
| Harada, N; Kazukawa, I; Kohno, Y; Matsunaga, T; Minagawa, M; Minamitani, K; Noda, H; Ohnuma, N; Someya, T; Wada, K; Wataki, K; Watanabe, T; Yasuda, T | 1 |
| Fukabori, Y; Kobayashi, M; Kosaku, N; Nakata, S; Takezawa, Y; Yamanaka, H | 1 |
| Hagen, KL; Halberg, F; Lange, RW; Ratajczak, HV; Sothern, RB; Thomas, PT; Vescei, P; Wu, J | 1 |
| Cooper, MR; Danesi, R; Ewing, MW; Jamis-Dow, CA; La Rocca, RV; Linehan, WM; Myers, CE | 1 |
| Bartsch, G; Graf, AH; Hartmann, H; Klocker, H; Schiller, CD; Schneider, MR | 1 |
| Milewich, L; Porter, JC | 1 |
| Heinonen, PK; Koivula, T; Pystynen, P | 1 |
1 review(s) available for dehydroepiandrosterone sulfate and Adenocarcinoma, Basal Cell
| Article | Year |
|---|---|
Circulating Sex Hormone Levels and Risk of Esophageal Adenocarcinoma in a Prospective Study in Men.
Topics: 17-alpha-Hydroxyprogesterone; Adenocarcinoma; Adult; Androstenedione; Case-Control Studies; Dehydroepiandrosterone Sulfate; Esophageal Neoplasms; Estradiol; Follicle Stimulating Hormone; Gonadal Steroid Hormones; Gonadotropins, Pituitary; Humans; Logistic Models; Luteinizing Hormone; Male; Middle Aged; Norway; Progesterone; Prolactin; Prospective Studies; Risk Factors; Sex Hormone-Binding Globulin; Testosterone | 2020 |
13 other study(ies) available for dehydroepiandrosterone sulfate and Adenocarcinoma, Basal Cell
| Article | Year |
|---|---|
SLCO2B1 and SLCO1B3 may determine time to progression for patients receiving androgen deprivation therapy for prostate cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Androgen Antagonists; Androgens; Antineoplastic Agents, Hormonal; Biological Transport; Dehydroepiandrosterone Sulfate; Disease Progression; Disease-Free Survival; DNA Mutational Analysis; Drug Resistance, Neoplasm; Genotype; Gonadotropin-Releasing Hormone; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasms, Hormone-Dependent; Orchiectomy; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Polymorphism, Single Nucleotide; Prostatic Neoplasms; Solute Carrier Organic Anion Transporter Family Member 1B3; Testosterone | 2011 |
Adrenal androgen concentrations in breast tumours and in normal breast tissue. The relationship to oestradiol metabolism.
Topics: 17-Hydroxysteroid Dehydrogenases; Adenocarcinoma; Adult; Aged; Androstenediol; Androstenediols; Breast; Breast Neoplasms; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Estrone; Female; Humans; Menopause; Middle Aged; Radioimmunoassay | 1984 |
Ovarian carcinoma serum markers and ovarian steroid activity--is there a link in ovarian cancer? A correlation of inhibin, tetranectin and CA-125 to ovarian activity and the gonadotropin levels.
Topics: Adenocarcinoma; Aged; Biomarkers, Tumor; Blood Proteins; CA-125 Antigen; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Female; Follicle Stimulating Hormone; Humans; Inhibins; Lectins, C-Type; Luteinizing Hormone; Ovarian Neoplasms; Ovary; Progesterone | 1995 |
Hormonal factors and prognosis in epithelial ovarian cancer: a multivariate analysis.
Topics: Adenocarcinoma; Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Aging; Androstenedione; Carcinoma, Endometrioid; Cystadenocarcinoma, Serous; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Female; Follicle Stimulating Hormone; Hormones; Humans; Luteinizing Hormone; Multivariate Analysis; Neoplasm Staging; Ovarian Neoplasms; Progesterone; Prognosis; Regression Analysis; Testosterone | 1993 |
Dehydroepiandrosterone-sulfate inhibits pancreatic carcinoma cell proliferation in vitro and in vivo.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Division; Dehydroepiandrosterone Sulfate; Humans; Mice; Mice, Nude; Pancreatic Neoplasms; Tumor Cells, Cultured | 1997 |
Lifelong treatment with oral DHEA sulfate does not preserve immune function, prevent disease, or improve survival in genetically heterogeneous mice.
Topics: Adenocarcinoma; Administration, Oral; Age Factors; Analysis of Variance; Animals; Antibody Formation; Cause of Death; Confidence Intervals; Dehydroepiandrosterone Sulfate; Double-Blind Method; Female; Immunity, Cellular; Immunization; Longevity; Male; Mammary Neoplasms, Animal; Mice; Mice, Inbred Strains; Placebos; Rodent Diseases; Survival Rate; T-Lymphocyte Subsets; Urologic Diseases | 1999 |
Estrogen secreting adrenal adenocarcinoma in an 18-month-old boy: aromatase activity, protein expression, mRNA and utilization of gonadal type promoter.
Topics: Adenocarcinoma; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Aromatase; Blotting, Western; Dehydroepiandrosterone Sulfate; Estradiol; Estrogens; Exons; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Gynecomastia; Humans; Hydrocortisone; Infant; Insulin; Luteinizing Hormone; Male; Promoter Regions, Genetic; Renin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Testis; Testosterone | 2000 |
Moderate dose diethylstilbestrol diphosphate therapy in hormone refractory prostate cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Diethylstilbestrol; Gonadotropin-Releasing Hormone; Humans; Injections, Intravenous; Male; Middle Aged; Prostatic Neoplasms; Testosterone | 2001 |
Surgical influence on murine immunity and tumor growth: relationship of body temperature and hormones with splenocytes.
Topics: Adenocarcinoma; Animals; Antigens, Surface; Body Temperature; Circadian Rhythm; Corticosterone; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Estrus; Female; Hormones; Light; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Spleen; T-Lymphocyte Subsets | 1992 |
Effect of suramin on human prostate cancer cells in vitro.
Topics: Adenocarcinoma; Androstenedione; Antineoplastic Agents; Cell Line; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Humans; In Vitro Techniques; Male; Prostatic Neoplasms; Suramin; Tumor Cells, Cultured | 1991 |
Growth-stimulating effect of adrenal androgens on the R3327 Dunning prostatic carcinoma.
Topics: Adenocarcinoma; Androstenedione; Animals; Castration; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Male; Neoplasms, Hormone-Dependent; Prostate; Prostatic Neoplasms; Rats; Rats, Inbred Strains; Stimulation, Chemical | 1991 |
In situ steroid sulfatase activity in human epithelial carcinoma cells of vaginal, ovarian, and endometrial origin.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Cell Line; Cystadenocarcinoma; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estrone; Female; Humans; Hydrolysis; Ovarian Neoplasms; Steryl-Sulfatase; Sulfatases; Uterine Neoplasms; Vaginal Neoplasms | 1987 |
Decreased serum level of dehydroepiandrosterone sulfate in postmenopausal women with ovarian cancer.
Topics: Adenocarcinoma; Age Factors; Aged; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Humans; Menopause; Middle Aged; Neoplasm Staging; Ovarian Neoplasms | 1987 |